Results 1 - 20 of 126.
1 2 3 4 5 7 Next »

Health - 06.10.2022
Small Cell Lung Cancer: New Approaches to Personalised Treatment
Small Cell Lung Cancer: New Approaches to Personalised Treatment
Small cell lung cancer (SCLC) is a particularly aggressive tumour, which has so far been treated with standardised measures. A study led by MedUni Vienna has shown for the first time that different SCLC subtypes have specific molecular characteristics, which is why those affected respond in different ways to cancer treatment.

Health - Psychology - 03.10.2022
New study on biological detectability of depression.
New study on biological detectability of depression.
More than 5% of all Austrians suffer from depression. However, little is known about the biological basis of this disease. In a new study, scientists led by Alexander Karabatsiakis from the Institute of Psychology at the University of Innsbruck have now observed a strong correlation between the severity of depression and the level of the stress hormone cortisol in hair.

Health - 29.09.2022
New diagnostic procedure for fish allergy explored
As early as 2018, a research team of the MedUni Vienna showed that strict avoidance of all types of fish is in fact only necessary for few fish-allergy sufferers. However, reliable tests to determine which types could be tolerated and eaten have not been available until now. In their current study, the researchers demonstrate that a new and effective diagnostic procedure.

Health - 28.09.2022
For the first time that ticks weaken skin’s immune response
Hitherto, scientists have not fully understood why ticks are such dangerous disease vectors. A research team led by Johanna Strobl and Georg Stary from MedUni Vienna's Department of Dermatology shows that tick saliva inhibits the skin's defence function, thereby increasing the risk of diseases such as tick-borne encephalitis (TBE) or Lyme disease.

Health - 27.09.2022
New findings on the effects of Covid-19 on the colon
Although SARS-CoV-2 infections mainly attack the lungs, in many cases they can also damage other organs, such as the colon: around 60% of patients experienced digestive tract impacts. Researchers at MedUni Vienna have analysed the manifestations of Covid-19 in the lungs and colon and pinpointed the differences at a molecular level.

Health - 23.09.2022
New therapeutic approach for anaplastic large cell lymphoma
New therapeutic approach for anaplastic large cell lymphoma
Anaplastic large cell lymphoma (ALCL) is an aggressive blood cancer that mainly affects children and adolescents, but it can also affect adults. A recent international study led by scientists from the Medical University Vienna and the Veterinary Medicine Vienna has now identified a new biomarker and effective therapeutic approach with the protein PDGFRβ and its downstream signaling pathway STAT3/5.

Health - 23.09.2022
SARS-CoV-2: fourth vaccination also protects cancer patients
SARS-CoV-2: fourth vaccination also protects cancer patients
A research team led by Matthias Preusser from MedUni Vienna's Division of Oncology had already demonstrated that cancer patients benefit from a third vaccination to protect them against COVID. A recent study now also supports fourth vaccination for this vulnerable group. However, passive immunisation by administering an antibody combination to cancer patients does not seem to provide adequate protection.

Health - Life Sciences - 16.09.2022
Alzheimer’s: up to 40% of cases are preventable
Early detection of Alzheimer's disease is critical if patients are to receive timely and appropriate care and potential treatments and preventive measures are to be used to the best possible effect. Scientists have so far identified several important risk factors that may trigger or accelerate dementia.

Health - 13.09.2022
Nature Inspired Peptide Shows Antitumoral Effect
Nature Inspired Peptide Shows Antitumoral Effect
Researchers at MedUni Vienna, Karl Landsteiner University of Health Sciences, University of Veterinary Medicine Vienna and Ludwig Boltzmann Institute for Cancer Research demonstrate an anti-tumor effect of certain nature-derived cyclic peptides. The study, which has now been published internationally, not only demonstrates the inhibition of cell division by these peptides, but even their ability to cause cell death of cancer cells.

Health - Pharmacology - 25.08.2022
New drug expands treatment opportunities for rheumatoid arthritis
In its final Phase III clinical trial, a new drug for treating rheumatoid arthritis has proved to be at least as effective as the current "gold standard" treatment for this autoimmune disease. This opens up new treatment options for affected patients. The results of the international multicentre study led by MedUni Vienna were recently published in the prestigious "New England Journal of Medicine".

Health - 24.08.2022
New role of immune cells in liver regeneration identified
If liver tissue has to be removed due to cancer or another liver disease, the organ usually regenerates quickly, soon becoming fully functional once again. Medical science has not yet completely understood the complex processes that enable tissue recovery following resection. Now, for the first time, a MedUni Vienna research team has discovered the vital role of immune cells that boost the production of liver cells.

Life Sciences - Health - 22.08.2022
Caterpillar-like bacteria crawl in our mouths
Caterpillar-like bacteria crawl in our mouths
Evolution of longitudinal division and multicellularity in oral bacteria. To survive in the oral cavity, bacteria have evolved to divide along their longitudinal axis without separating from each other. This is what a research team led by cell biologist Silvia Bulgheresi of the University of Vienna and microbial geneticist Frédéric Veyrier of the Institut national de la recherche scientifique (INRS) recently discovered.

Health - Life Sciences - 22.08.2022
First treatment for liver damage in alpha-1-antitrypsin deficiency
Alpha-1-antitrypsin deficiency is a genetic disorder that often leads to serious damage to the lungs and liver. Although there are already therapeutic measures available for alleviating pulmonary emphysema caused by the missing enzyme, the precise background to the associated liver damage was hitherto unclear and there was no known treatment option.

Health - 12.08.2022
First proof of the benefits and risks of dual antiplatelet therapy after bypass surgery
A recent analysis shows that a combination of two antiplatelet drugs may be beneficial for patients undergoing coronary artery bypass graft surgery but may also carry a risk. This new finding by an international research group with lead author Sigrid Sandner from MedUni Vienna's Department of Cardiac Surgery suggests that treating doctors should carefully consider the use of these drugs.

Health - Life Sciences - 10.08.2022
New prognostic marker discovered for multiple sclerosis severity
It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods. A MedUni Vienna study now shows for the first time that the retina can be used as a prognostic marker. Analyses revealed that retinal layer thinning as a result of an MS relapse predicts the severity of future relapses and, hence, the likelihood of disability.

Health - Life Sciences - 09.08.2022
Breast cancer: new drug shrinks brain metastases
Breast cancer: new drug shrinks brain metastases
An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy drug that, according to current findings, opens up a completely new avenue in oncological research and targeted therapy.

Environment - Health - 05.08.2022
Ragweed allergy: aggressiveness of pollen is determined by its place of origin and by the environment
Ragweed allergy: aggressiveness of pollen is determined by its place of origin and by the environment
The different geographic and climatic regions from which ragweed pollen originates, as well as the degree of environmental pollution, may influence the severity of allergic reactions such as hay fever and asthma. Pollen from plants in different areas exhibit different levels of aggressiveness. This is the conclusion reached by an inter-university study team led by MedUni Vienna and involving the University of Vienna and the University of Natural Resources and Applied Life Sciences.

Life Sciences - Health - 02.08.2022
Receptor FIBCD1 newly identified in neuro-developmental disorders
A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder. Using data from two young patients with neurological symptoms, the researchers from both groups found evidence of a novel function for the FIBCD1 gene in the brain, and a potentially pivotal role in diseases such as autism, ADHD, schizophrenia, and neurodegenerative disorders including Alzheimer-s.

Health - Life Sciences - 26.07.2022
Potential for improving premature baby care
One in two premature babies receives transfusions of red blood cells (RBC) due to anaemia. There are no generally accepted clinical guidelines for the degree of anaemia necessitating blood transfusions. MedUni Vienna researchers have now conducted a critical review of the currently available literature.

Health - Career - 20.07.2022
Hertha Firnberg Fellow at the Center for Medical Physics and Biomedical Engineering
The Hertha Firnberg Fellowship was established by the FWF to support highly qualified young female researchers in their university careers. In 2021, the grant was awarded to Anna Breger, who is now starting her research work as a postdoc at MedUni Vienna as part of this programme. With her research project "Image based Data Evaluation Analyses and Medical Application", Anna Breger and her new colleagues at the Center for Medical Physics and Biomedical Engineering aim to improve the generalisation of automated quality assessment of digital image data.
1 2 3 4 5 7 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |